- Home
- TWIN vs TVGN Comparison
TWIN vs TVGN Comparison
Compare TWIN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TWIN | TVGN |
|---|---|---|
| Founded | 1918 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.7M | 63.9M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | TWIN | TVGN |
|---|---|---|
| Price | $15.00 | $5.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 41.5K | ★ 522.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.08% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.53 | N/A |
| Revenue | ★ $340,738,000.00 | N/A |
| Revenue This Year | $10.79 | N/A |
| Revenue Next Year | $8.43 | N/A |
| P/E Ratio | $9.69 | ★ N/A |
| Revenue Growth | ★ 15.45 | N/A |
| 52 Week Low | $6.16 | $0.14 |
| 52 Week High | $19.63 | $10.76 |
Technical Indicators
Market Signals| Indicator | TWIN | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 36.72 | 69.86 |
| Support Level | $14.80 | $0.53 |
| Resistance Level | $16.62 | $10.76 |
| Average True Range (ATR) | 0.84 | 0.80 |
| MACD | -0.34 | 0.46 |
| Stochastic Oscillator | 11.31 | 51.76 |
Price Performance
Historical ComparisonAbout TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.